Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 04 04:00PM ET
2.13
Dollar change
+0.11
Percentage change
5.45
%
IndexRUT P/E- EPS (ttm)-1.30 Insider Own8.82% Shs Outstand95.34M Perf Week-13.06%
Market Cap203.07M Forward P/E- EPS next Y-1.11 Insider Trans0.00% Shs Float86.93M Perf Month-13.41%
Income-138.96M PEG- EPS next Q-0.33 Inst Own39.66% Short Float10.52% Perf Quarter63.85%
Sales2.63M P/S77.21 EPS this Y2.38% Inst Trans-4.23% Short Ratio4.52 Perf Half Y17.03%
Book/sh0.79 P/B2.68 EPS next Y13.97% ROA-70.82% Short Interest9.14M Perf Year-10.13%
Cash/sh0.89 P/C2.38 EPS next 5Y- ROE-131.82% 52W Range1.14 - 3.33 Perf YTD4.41%
Dividend Est.- P/FCF- EPS past 5Y1.04% ROI-85.11% 52W High-36.04% Beta0.41
Dividend TTM- Quick Ratio3.88 Sales past 5Y309.32% Gross Margin-525.70% 52W Low86.96% ATR (14)0.26
Dividend Ex-Date- Current Ratio3.88 EPS Y/Y TTM10.78% Oper. Margin-5652.55% RSI (14)44.75 Volatility13.85% 8.53%
Employees233 Debt/Eq1.29 Sales Y/Y TTM-72.95% Profit Margin-5283.73% Recom1.00 Target Price9.00
Option/ShortYes / Yes LT Debt/Eq1.21 EPS Q/Q3.70% Payout- Rel Volume1.16 Prev Close2.02
Sales Surprise-17.35% EPS Surprise3.06% Sales Q/Q-17.20% EarningsNov 08 AMC Avg Volume2.02M Price2.13
SMA20-6.58% SMA50-8.67% SMA2007.64% Trades Volume2,343,155 Change5.45%
Date Action Analyst Rating Change Price Target Change
Feb-28-24Initiated JMP Securities Mkt Outperform $4
Mar-31-23Initiated Evercore ISI Outperform
Mar-28-23Initiated B. Riley Securities Buy $8
Oct-31-22Initiated Piper Sandler Overweight $6
Aug-22-22Downgrade Goldman Neutral → Sell $2
Dec-15-21Resumed Goldman Neutral $15
Oct-15-21Resumed BTIG Research Buy $20
Jan-20-21Downgrade Robert W. Baird Outperform → Underperform $8
Jul-26-19Initiated Robert W. Baird Outperform $17
Mar-15-19Initiated Raymond James Outperform
Feb-29-24 04:05PM
Feb-21-24 07:00AM
Feb-12-24 07:00AM
Feb-08-24 04:30PM
Jan-31-24 04:00PM
07:00AM Loading…
Jan-17-24 07:00AM
Jan-10-24 04:30PM
Dec-07-23 04:30PM
Nov-20-23 07:00AM
Nov-08-23 06:43PM
04:05PM
Nov-07-23 04:30PM
Oct-12-23 05:00PM
Oct-11-23 07:10AM
Oct-10-23 07:00AM
04:05PM Loading…
Oct-04-23 04:05PM
Sep-27-23 04:01PM
Sep-13-23 04:30PM
Sep-05-23 07:00AM
Aug-16-23 04:30PM
Aug-15-23 07:00AM
Aug-09-23 04:05PM
Aug-07-23 07:00AM
Jul-17-23 07:00AM
Jul-04-23 06:55AM
Jun-13-23 07:00AM
Jun-08-23 07:00AM
Jun-01-23 04:30PM
May-24-23 05:00PM
May-16-23 06:05AM
04:05PM Loading…
May-11-23 04:05PM
May-03-23 07:00AM
Apr-21-23 06:05AM
Apr-17-23 07:01AM
07:00AM
Apr-10-23 07:00AM
Apr-04-23 06:30PM
Mar-15-23 07:00AM
Mar-11-23 07:18AM
Mar-09-23 04:05PM
Mar-02-23 07:00AM
Feb-27-23 04:06PM
04:05PM
Feb-14-23 07:00AM
Jan-25-23 05:34AM
Jan-24-23 07:00AM
Jan-18-23 05:30PM
Dec-15-22 04:31PM
04:30PM
Dec-13-22 07:00AM
Dec-05-22 08:30AM
Nov-21-22 07:30AM
Nov-17-22 07:00AM
Nov-10-22 09:00AM
Nov-03-22 06:04PM
04:05PM
Oct-25-22 07:01AM
07:00AM
Oct-19-22 09:43AM
07:00AM
Oct-17-22 07:00AM
Sep-20-22 07:00AM
Sep-12-22 07:00AM
Sep-01-22 04:05PM
Aug-17-22 07:00AM
Aug-15-22 04:05PM
Aug-10-22 04:05PM
Aug-04-22 04:05PM
Aug-01-22 06:38AM
Jul-26-22 07:00AM
Jul-21-22 04:06PM
04:05PM
Jul-05-22 08:00AM
Jun-10-22 08:00AM
Jun-08-22 04:05PM
08:51AM
Jun-02-22 08:00AM
May-31-22 08:00AM
May-17-22 05:00PM
May-09-22 08:32AM
May-06-22 07:30PM
May-05-22 04:05PM
May-02-22 07:00AM
Apr-27-22 04:05PM
Apr-12-22 04:35PM
Mar-30-22 07:00AM
Mar-17-22 12:14PM
Mar-10-22 04:05PM
Mar-08-22 05:15PM
Feb-24-22 07:00AM
Feb-22-22 05:34AM
Feb-08-22 04:05PM
07:00AM
Feb-07-22 10:45AM
Jan-25-22 04:05PM
Jan-13-22 07:00AM
Jan-12-22 06:15AM
Jan-05-22 05:14PM
Jan-04-22 07:00AM
Dec-30-21 07:00AM
Gritstone bio, Inc. clinical-stage biotechnology company, which engages in developing the next generation of cancer immunotherapies to fight multiple cancer types. The company was founded by Andrew Allen, Timothy Chan, Mark Cobbold, Graham Lord, Naiyer Rizvi and Jean-Charles Soria in August 2015 and is headquartered in Emeryville, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Economides VassilikiSee RemarksMay 23Buy1.9012,00022,829214,058May 24 05:24 PM